Table 1.
Patient characteristics
| HIFU ablation (n = 47) | Percutaneous RFA (n = 59) | P | |
|---|---|---|---|
| Age (years) | 62 (34–84) | 60 (23–83) | 0.095 |
| Male/female | 36:11 | 43:16 | 0.663 |
| Hepatitis B virus infection | 42 (79.2%) | 46 (80.7%) | 0.849 |
| Hepatitis C virus infection | 9 (17%) | 10 (17.2%) | 0.971 |
| Ascites | |||
| Absent | 41 (87.2%) | 57 (96.6%) | 0.148 |
| Present | 6 (12.8%) | 2 (3.4%) | |
| Child–Pugh class | |||
| A | 31 (66%) | 54 (91.5%) | 0.001 |
| B | 16 (34%) | 5 (8.5%) | |
| Total bilirubin (umol/l) | 14 (7–50) | 13 (4–57) | 0.371 |
| Creatinine (umol/l) | 86 (44–878) | 78 (46–912) | 0.281 |
| Albumin (g/l) | 39 (24–46) | 39 (23–46) | 0.388 |
| International normalized ratio | 1.0 (0.8–1.5) | 1.1 (0.9–1.4) | 0.124 |
| Platelet count (1 × 109) | 104 (17–268) | 98 (34–228) | 0.731 |
| Alpha-fetoprotein (ng/ml) | 18 (2–937) | 16 (2–10050) | 0.694 |
HIFU, high-intensity focused ultrasound; RFA, radiofrequency ablation.